CXCR4 and lung cancer: Inhibiting the SDF-1/CXCR4 axis with a neutralizing antibody or transfection with an antisense oligonucleotide against CXCR4 significantly reduced invasion, migration and adhesion of lung cancer cell lines in vitro [7].